Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Celadon Pharmaceuticals PLC, a pioneering UK-based company, has announced the on-schedule completion of its eighth cannabis harvest of the year, with plans to achieve a total of 15 harvests in 2024. The company’s custom indoor hydroponic facility supports this high-frequency harvest schedule, enhancing yields and meeting their £1.4 million annual sales contracts with two UK pharmaceutical companies. Celadon is addressing UK supply issues by providing a steady supply of pharmaceutical-grade cannabis, positioning itself as a key player in the domestic market.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.
